Selinexor combined with bortezomib, lenalidomide, and dexamethasone for the treatment of newly diagnosed multiple myeloma with extramedullary disease by Junjing Yin, Xia Zhou, Xuemei Li, Chenglu Yuan, Xiaoxia Chu, Lumei Hao, Hongying Wu, Yuping Zhong

Get full text

Treatment efficacy for relapsed/refractory multiple myeloma patients with gain/amplification of 1q21 by Xia Zhou, Hongying Wu, Lumei Hao, Liyan Wei, Xuemei Li, Junjing Yin, Qianru Yu, Zhanzhi Xie, Yuping Zhong, Ting Gao

Get full text

Lactate-related gene signatures as prognostic predictors and comprehensive analysis of immune profiles in nasopharyngeal carcinoma by Changlin Liu, Chuping Ni, Chao Li, Hu Tian, Weiquan Jian, Yuping Zhong, Yanqing Zhou, Xiaoming Lyu, Yuanbin Zhang, Xiao-Jun Xiang, Chao Cheng, Xin Li

Get full text

Real-world analysis of treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with newly diagnosed or relapsed/refractory multiple myeloma by Luqun Wang, Wei Yang, Yafei Wang, Ting Niu, Rong Fu, Yuping Zhong, Wenbin Qian, Kaiyang Ding, Kai Sun, Hong Liu, Baijun Fang, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu

Get full text